Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Exp Dermatol. 2006 Sep;31(5):638-41. Epub 2006 Jun 15.

    A randomised double-blind study comparing the effect of 1072-nm light against placebo for the treatment of herpes labialis.

    Source

    Newlands Medical Centre, Borough Road, Middlesbrough, UK. g.hargate@ntlworld.com

    Abstract

    BACKGROUND:

    Previous research demonstrated that 1072-nm narrowband laser light is effective in the treatment of cold sores.

    AIM:

    To evaluate the efficacy of an over-the-counter cold-sore treatment device (Virulite CS) incorporating 1072-nm light-emitting diodes.

    METHODS:

    A randomised, prospective, double-blind, self-reported study was performed to compare the efficacy of at least six 3-min treatments of 1072-nm narrowband light against placebo, in the treatment of herpes labialis.

    RESULTS:

    The 1072-nm light-emitting diode device reduced cold-sore healing time to 6.3 days compared with 9.4 days for placebo (P=0.048). The time the cold sore took to form a crust was also reduced from 2.00 days for those treated with 1072-nm light, compared with 2.88 days for placebo (P=0.059)

    CONCLUSIONS:

    The significant difference between the mean healing times in the two groups demonstrates that the Virulite CS device is an effective means of treating herpes labialis.

    PMID:
    16780494
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk